Medmain Inc. is a company that develops software products aimed at enhancing pathology diagnosis through advanced technology. Founded in 2018 and headquartered in Fukuoka City, Japan, with additional offices in Tokyo and the United States, Medmain offers several key products. Its flagship software, PidPort, utilizes machine learning and artificial intelligence for rapid and accurate pathology analysis. The company also provides Medteria, an online platform that grants medical students access to educational resources, and offers diagnostic imaging services. Medmain's solutions are designed to improve operational efficiency within medical institutions and support drug discovery efforts for pharmaceutical companies and contract research organizations. Through its innovative approach, Medmain seeks to make medical services more accessible and efficient.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.